Article info

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
Free

Authors

  • Serena Bugatti Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Ludovico De Stefano Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Silvia Balduzzi Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy PubMed articlesGoogle scholar articles
  • Maria Immacolata Greco Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy PubMed articlesGoogle scholar articles
  • Terenzj Luvaro Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy PubMed articlesGoogle scholar articles
  • Irene Cassaniti Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Laura Bogliolo Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy PubMed articlesGoogle scholar articles
  • Iolanda Mazzucchelli Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Bernardo D’Onofrio Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Michele di Lernia Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Eleonora Mauric Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Daniele Lilleri Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy PubMed articlesGoogle scholar articles
  • Fausto Baldanti Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Antonio Manzo Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  • Carlomaurizio Montecucco Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyDepartment of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Serena Bugatti, Division of Rheumatology, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy; serena.bugatti{at}unipv.it
View Full Text

Citation

Bugatti S, De Stefano L, Balduzzi S, et al
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis

Publication history

  • Received May 26, 2021
  • Accepted June 21, 2021
  • First published June 25, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.